Impact of Per Oral Pyloromyotomy (POP) on Glycemic Control in Diabetes

Description

This study will assess changes in glycemic control in 40 patients with diabetes who undergo per-oral pyloromyotomy (POP) for medically refractory gastroparesis.

Conditions

Diabetes Mellitus, Gastroparesis With Diabetes Mellitus, Gastroparesis

Talk to us

Study Overview

On this page

Study Details

Study overview

This study will assess changes in glycemic control in 40 patients with diabetes who undergo per-oral pyloromyotomy (POP) for medically refractory gastroparesis.

Impact of Endoscopic Per-Oral Pyloromyotomy (POP) on Glycemic Control in Gastroparesis Patients With Poorly Controlled Diabetes Mellitus

Impact of Per Oral Pyloromyotomy (POP) on Glycemic Control in Diabetes

Condition
Diabetes Mellitus
Intervention / Treatment

-

Contacts and Locations

Cleveland

Cleveland Clinic Foundation, Cleveland, Ohio, United States, 44195

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Patients 18 years of age and older
  • 2. Patients with gastroparesis with an average HbA1c\> 7.5% over the past 3 months
  • 3. Patient that have a diagnosis of gastroparesis established by documented delayed gastric emptying by either a wireless motility capsule study or a nuclear gastric emptying study, with no evidence of gastric obstruction.
  • 4. Patients are able to complete all study requirements
  • 1. Patients \<18 years of age
  • 2. Patients with gastroparesis with an average HbA1c\< 7.5% over the past 3 months
  • 3. Patients unable or refuse to complete the study requirements
  • 4. Patients who are unable or refuse to wear a CGM sensor
  • 5. Patients with insulin pumps
  • 6. Patients who already use a CGM

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Matthew Allemang,

Mathew Allemang, MD, PRINCIPAL_INVESTIGATOR, The Cleveland Clinic

Study Record Dates

2026-06